Steven Cohen Merrimack Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.7 - $6.06 $2.83 Million - $4.64 Million
765,886 Added 228.55%
1,100,994 $4.13 Million
Q2 2022

Aug 15, 2022
SELL
$4.89 - $7.13 $32,161 - $46,894
-6,577 Reduced 1.92%
335,108 $1.99 Million
Q3 2021

Nov 15, 2021
BUY
$4.3 - $6.39 $568,124 - $844,259
132,122 Added 63.05%
341,685 $1.65 Million
Q2 2021

Aug 16, 2021
BUY
$6.04 - $7.77 $1.27 Million - $1.63 Million
209,563 New
209,563 $1.34 Million

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email